What is Fervent Synergies share price return in the past 10 years?

Fervent Synergies Ltd share price has declined -9.6% annually (CAGR) over the past ten years.

Fervent Synergies Ltd - Stock Valuation and Financial Performance

Name: Fervent Synergies
Brand: Fervent Synergies

BSE: 533896 | NSE: | Trading | Small Cap

Place order

Fervent Synergies Share Price

₹19.78 -0.61 -2.99%
as on 20-Dec'24 16:59

DeciZen - make an informed investing decision on Fervent Synergies

Based on:

Data

M-Cap below 100cr DeciZen not available

Fervent Synergies stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

59.3 Cr.

52-wk low:

14.6

52-wk high:

27.8

Is Fervent Synergies Ltd an attractive stock to invest in?

1. Is Fervent Synergies Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Fervent Synergies Ltd is a below average quality company.

2. Is Fervent Synergies Ltd undervalued or overvalued?

The key valuation ratios of Fervent Synergies Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Fervent Synergies Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Fervent Synergies Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Fervent Synergies:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	9%	7.7%	8.9%	2.8%	4.3%	1.1%	0.6%	-0.5%	1%	-34.8%	-
Value Creation Index ⓘ	-0.4	-0.5	-0.4	-0.8	-0.7	-0.9	-1.0	-1.0	-0.9	-3.5	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	3.5	3.7	39.2	5.5	16.7	7.4	2.2	0.9	4.6	24.3	24
Sales YoY Gr.	-	4.6%	966.8%	-85.9%	202.5%	-55.9%	-69.9%	-61.5%	444.7%	425.1%	-
Adj EPS ⓘ	0.7	0.6	0.6	0.3	0.3	0.1	0.1	-0	0.1	-4.3	-4.3
YoY Gr.	-	-1.5%	-4.7%	-57.4%	23.1%	-78.1%	-14.3%	-166.7%	NA	-5450%	-
BVPS (₹) ⓘ	12.1	12.8	13.6	13.9	14.3	14.2	14.4	14.3	14.4	10.1	10.2
Adj Net Profit ⓘ	2	1.9	1.8	0.8	1	0.2	0.2	-0.1	0.2	-12.8	-13
Cash Flow from Ops. ⓘ	1.1	-6.3	-1.8	2.9	11.6	2	0.2	-2.2	-0.1	-0.2	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	0	0	0	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	24%	7.8%	122.4%	425.1%
Adj EPS ⓘ	-223.3%	-268%	-514.7%	-5450%
BVPSⓘ	-2%	-6.6%	-11%	-29.7%
Share Price	-9.6%	0.5%	8.9%	26.3%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	6	5.1	4.6	1.9	2.2	0.5	0.4	-0.3	0.5	-34.9	-42.5
Op. Profit Mgn % ⓘ	83.3	78	6.9	19.9	8.4	6.2	12.5	-0.6	10.3	-52.5	-52.9
Net Profit Mgn % ⓘ	55.6	51.9	4.7	14.4	5.7	3	7.9	-13.7	5	-52.8	-53
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0	0
Working Cap Days ⓘ	1,627	2,022	249	1,687	373	557	2,538	10,065	2,125	377	1,661
Cash Conv. Cycle ⓘ	0	0	27	214	41	175	478	374	24	4	1,659

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 122.40%

Sales growth is good in last 4 quarters at 441.68%

Return on Equity is Poor

Latest Financials - Fervent Synergies Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-4.3	-
TTM Sales (₹ Cr.)	24.4	-
BVPS (₹.) ⓘ	10.2	-
Reserves (₹ Cr.) ⓘ	-	-
P/BV ⓘ	1.95	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	14.60 / 27.79
All Time Low / High (₹)	7.22 / 95.00
Market Cap (₹ Cr.)	59.3
Equity (₹ Cr.)	30
Face Value (₹)	10
Industry PE ⓘ	62.3

Management X-Ray of Fervent Synergies:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Fervent Synergies

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Fervent Synergies

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	3.51	3.67	39.15	5.51	16.67	7.35	2.21	0.85	4.63	24.31
Operating Expenses ⓘ	0.59	0.81	36.46	4.41	15.26	6.90	1.94	1.03	4.15	37.07
Manufacturing Costs	0.06	0.05	3.47	0.37	1.53	0.48	0.04	0.09	0.12	0.06
Material Costs	0	0	31.94	3.46	13.03	5.85	1.39	0	3.47	22.08
Employee Cost	0.12	0.13	0.14	0.14	0.16	0.25	0.24	0.30	0.27	0.29
Other Costs ⓘ	0.41	0.62	0.91	0.44	0.54	0.32	0.26	0.64	0.29	14.64
Operating Profit ⓘ	2.92	2.87	2.68	1.10	1.40	0.45	0.28	-0.18	0.48	-12.76
Operating Profit Margin (%)	83.3%	78.0%	6.9%	19.9%	8.4%	6.2%	12.4%	-20.9%	10.3%	-52.5%
Other Income ⓘ	0.02	0.04	0.83	0.06	0.41	0.03	0	0.02	0	0
Interest ⓘ	0.04	0.01	0.19	0.01	0.07	0.15	0.01	0	0	0.04
Depreciation ⓘ	0.01	0.02	0.01	0.01	0.01	0.02	0.04	0.04	0.04	0.04
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	2.89	2.88	3.31	1.14	1.74	0.31	0.23	-0.20	0.44	-12.85
Tax ⓘ	0.94	0.97	0.90	0.31	0.50	0.07	0.06	0.04	0.21	0
Profit After Tax	1.95	1.91	2.41	0.83	1.23	0.24	0.17	-0.24	0.23	-12.84
PAT Margin (%)	55.6%	51.9%	6.2%	15.1%	7.4%	3.2%	7.9%	-27.9%	5.0%	-52.8%
Adjusted EPS (₹)	0.7	0.6	0.8	0.3	0.4	0.1	0.1	-0.1	0.1	-4.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	36.44	38.34	40.75	41.80	42.78	42.58	43.04	42.99	43.22	30.38
Share Capital ⓘ	30	30	30	30	30	30	30	30	30	30
Reserves ⓘ	6.44	8.34	10.75	11.80	12.78	12.58	13.04	12.99	13.22	0.38
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	0	0	0	0	0	0	0	0	0	0
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Trade Payables	0	0	0	0	0	0	0	0	0	0
Others Liabilities ⓘ	1.02	1.02	1.49	0.39	0.71	0.83	0.69	0.14	0.24	0.14
Total Liabilities ⓘ	37.46	39.36	42.24	42.20	43.49	43.40	43.74	43.12	43.45	30.51
Fixed Assets
Gross Block	0.58	0.58	0.58	0.58	0.59	0.80	0.81	0.81	0.82	0.82
Accumulated Depreciation	0.10	0.12	0.13	0.14	0.15	0.18	0.21	0.25	0.29	0.33
Net Fixed Assetsⓘ	0.48	0.45	0.45	0.44	0.43	0.62	0.59	0.56	0.53	0.49
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investmentsⓘ	0	2.16	1.49	4.10	17.88	17.45	17.74	0	0	0
Inventories	0	0	1.19	0	0	1.39	0	0	0	0
Trade Receivables	0	0	4.57	0.70	3.02	2.65	1.75	0	0.60	0
Cash Equivalents	20.71	12.29	11.41	15.63	13.17	14.90	5.08	0.29	0.21	0.01
Others Assetsⓘ	16.27	24.46	23.12	21.33	8.99	6.39	18.57	42.27	42.12	30.01
Total Assets ⓘ	37.46	39.36	42.24	42.20	43.49	43.40	43.74	43.12	43.45	30.51

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	1.06	-6.28	-1.82	2.85	11.58	1.95	0.18	-2.19	-0.07	-0.20
PBT ⓘ	2.89	2.88	3.31	1.14	1.74	0.31	0.23	-0.20	0.44	-12.85
Adjustment ⓘ	0.05	0.02	-0.52	0.01	0.01	0.07	0.04	0.03	0.04	14.36
Changes in Working Capital ⓘ	-0.92	-8.22	-3.86	2.22	10.08	1.89	-0.02	-1.92	-0.46	-1.56
Tax Paid ⓘ	-0.96	-0.96	-0.75	-0.51	-0.25	-0.32	-0.07	-0.10	-0.10	-0.16
Cash Flow From Investing Activity ⓘ	1	-2.14	1.19	-2.39	-14.03	-0.22	0	2.40	0	0
Capex	0	0	-0.01	0	-0.01	-0.21	-0.01	-0.01	0	0
Net Investments	1	-2.16	0.67	-2.39	-14.03	-0.01	0	2.39	0	0
Others ⓘ	0	0.03	0.53	0	0	0	0	0.02	0	0
Cash Flow From Financing Activityⓘ	6	0	0	0	0	0	0	0	0	0
Net Proceeds from Shares ⓘ	6	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	0	0	0
Net Cash Flow ⓘ	8.06	-8.41	-0.63	0.46	-2.46	1.73	0.18	0.21	-0.07	-0.20

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	6.01	5.1	6.09	2.01	2.92	0.55	0.41	-0.55	0.53	-34.9
ROCE (%)	9.04	7.73	8.87	2.77	4.27	1.07	0.57	-0.46	1.02	-34.8
Asset Turnover Ratio	0.11	0.1	0.96	0.13	0.39	0.17	0.05	0.02	0.11	0.66
PAT to CFO Conversion(x)	0.54	-3.29	-0.76	3.43	9.41	8.13	1.06	N/A	-0.3	N/A
Working Capital Days
Receivable Days	0	0	43	175	41	141	363	0	47	0
Inventory Days	0	0	11	0	0	69	0	0	0	0
Payable Days	0	0	0	0	0	0	0	0	0	0

Fervent Synergies Ltd Stock News

Fervent Synergies Ltd FAQs

What is the share price of Fervent Synergies?

Company share prices are keep on changing according to the market conditions. The closing price of Fervent Synergies on 20-Dec-2024 16:59 is ₹19.78.

What is the market cap of Fervent Synergies?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Dec-2024 16:59 the market cap of Fervent Synergies stood at ₹59.34.

What is the P/E ratio of Fervent Synergies?

The latest P/E ratio of Fervent Synergies as of 20-Dec-2024 16:59 is 0.00.

What is the P/B ratio of Fervent Synergies?

The latest P/B ratio of Fervent Synergies as of 20-Dec-2024 16:59 is 1.95.

What is the 52-week high and low of Fervent Synergies?

The 52-week high of Fervent Synergies is ₹27.79 and the 52-week low is ₹14.60.

What is the TTM revenue of Fervent Synergies?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Fervent Synergies is ₹24.41 ( Cr.) .

About Fervent Synergies Ltd

Fervent Synergies Ltd. was incorporated as a public Limited Company on July 6, 2009, in the name of Fervent Pharma Synergies Limited, under the Companies Act, 1956 and obtained certificate of commencement of business on August 13, 2009 from the Registrar of Companies, Maharashtra, Mumbai

Name of the company was changed from Fervent Pharma Synergies Limited to Fervent Synergies Limited with effect from 24th July, 2012, vide ‘Fresh Certificate of Incorporation Consequent upon Change of Name’ issued by Government of India - Ministry of Corporate Affairs, Registrar of Companies, Maharashtra, Mumbai.

Business area of the company

The company is in the business of dealing in Pharmaceutical and Chemical products, import-export, trading and distribution of various chemicals, solvents, APIs, intermediates & other bulk drugs. They are located in Mumbai, Maharashtra.